Mussallem Michael A 的 Form 4 申報
Edwards Lifesciences Corp（EW），2022/1/7 申報
- 申報編號
- 0001225208-22-000614
- 申報時間
- 2022/1/7
- 交易日
- 2022/1/6
- 申報延遲
- 1 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 6 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $403.2 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Mussallem Michael ACIK 0001204551 | 董事、高階主管（董事長、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/1/6 | Common Stock | M行使選擇權取得 | +45,050 | $21.76 | +$980,288 | 233,051.82 | 直接 | |
| 2022/1/6 | Common Stock | S賣出處分 | −300 | $125.17F2 | −$37,551 | 232,751.82 | 直接 | |
| 2022/1/6 | Common Stock | G贈與處分 | −12,500 | $0.00 | $0 | 220,251.82 | 直接 | |
| 2022/1/6 | Common Stock | S賣出處分 | −12,600 | $124.45F3 | −$1,568,070 | 207,651.82 | 直接 | |
| 2022/1/6 | Common Stock | S賣出處分 | −19,650 | $123.49F4 | −$2,426,578.5 | 188,001.82 | 直接 | |
| 2022/1/6 | Common Stock | G贈與取得 | +12,500 | $0.00 | $0 | 3,247,787 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/1/6 | Common Stock | M行使選擇權處分 | −45,050 | $0.00 | $0 | 180,200 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $125.07 to $125.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $124.00 to $124.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $122.99 to $123.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
備註
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.